| 摘要 |
<p>The invention discloses a novel peptide-human ATP-dependent serine proteolytic enzyme 11, polynucloetide coding this peptide and the method producing this peptide by DNA recombination techniques. This invention also discloses the therapeutical methods for several diseases, such as mitochondrion illness, decompensation illness which is related to substance and energy, growth and development impediment illness et al. This invention also discloses an antagonist against this peptide and its therapeutical effect. The invention also discloses the use of this polynucleotide coding the novel human ATP-dependent serine proteolytic enzyme 11.</p> |
